National Institute of Pharmaceutical Education and Research, S.A.S. Nagar

What is the average package at National Institute of Pharmaceutical Education and Research, S.A.S. Nagar?

The average package at National Institute of Pharmaceutical Education and Research, S.A.S. Nagar (NIPER Mohali) sits in the ₹6-8 LPA band for the 2025 placement cycle, with a verified median of ₹6.05 LPA and a highest package of ₹15 LPA offered by Pfizer. In 2025 the institute placed 79.00% of its postgraduate batch (213 of 268 students), an improvement on the 76.90% placed in 2024 when the highest package was ₹12 LPA. NIPER Mohali is a government-funded institute of national importance focused entirely on pharmaceutical sciences, so its salary outcomes are driven by drug-discovery, R&D, regulatory and formulation roles rather than mass IT hiring. The numbers below are modest in absolute terms but strong for the pharma PG segment, where NIPER Mohali consistently ranks among the top recruiters' preferred talent pools.

It is worth noting that NIPER Mohali does not publish a single official mean CTC figure; portals report the central tendency through the median (₹6.05 LPA in 2025) and an average band of ₹6-8 LPA. The headline that matters for an aspirant is the combination of a high placement rate (79.00% in 2025) and a steadily rising median, which together signal dependable, repeatable outcomes year on year.

Branch/Course-Wise Package Breakdown

NIPER Mohali runs distinct postgraduate streams - M.Pharm specialisations, MS (Pharm), MBA (Pharm) and M.Tech - and pay varies meaningfully by branch. The table below answers the question "which course earns the most at NIPER Mohali?" using the 2025 cycle. Read it as the highest CTC achievable per branch alongside the key recruiter driving that figure; M.Pharm remains the volume engine while MBA (Pharm) and MS (Pharm) chase the premium offers. Use the highest-CTC column as the ceiling for each stream, not the typical pay, which clusters nearer the ₹6 LPA median.

The takeaway for 2025 is clear: M.Pharm streams supplied more than half of all offers (120+ placements) and produced the single highest CTC of ₹15 LPA at Pfizer, while MBA (Pharm) delivered the strongest typical pay because its marketing and strategy roles command higher base salaries than R&D bench positions. An aspirant choosing M.Pharm at NIPER Mohali should expect a dependable ₹6 LPA median with a realistic shot at double-digit LPA, whereas MBA (Pharm) and MS (Pharm) candidates trade slightly fewer openings for a higher average.

Year-Wise Package Trend

This table tracks how NIPER Mohali's pay has moved across the last three placement cycles, answering "has the package increased over the years at NIPER Mohali?" The institute does not release an official average CTC, so the median is the most reliable trend line, shown next to the highest package each year. Read the median column as the central salary an average placed student took home and the highest column as the top single offer recorded that year.

The trajectory is consistently upward: the median climbed from ₹5.50 LPA in 2023 to ₹5.80 LPA in 2024 and ₹6.05 LPA in 2025, while the highest package rose from ₹10 LPA to ₹12 LPA to ₹15 LPA over the same window. For an applicant, this steady year-on-year lift, combined with the placement rate rising to 79.00% in 2025 from 76.90% in 2024, indicates a strengthening pharma hiring market and growing recruiter confidence in NIPER Mohali graduates rather than a one-off spike.

Notable Offers & Package Distribution

The standout offer of the 2025 cycle at NIPER Mohali was the ₹15 LPA package from Pfizer, up from the ₹12 LPA peak of 2024, with Novartis, Dr. Reddy's, Syngene and Biocon rounding out the premium recruiters. The 2025 drive produced 250+ total offers from 40+ companies, a roughly 12% increase over the 223 offers of 2024, and the placement cell ran 30+ training workshops plus 150+ internships (many at Pfizer) that converted into pre-placement offers.

Package distribution at NIPER Mohali is bottom-heavy and typical of a pharma PG institute: the large mass-recruiter cluster sits in the ₹5.5-7 LPA range, where firms like Dr. Reddy's, Zydus and Himalaya hire in bulk for pharmaceutics, regulatory, QA/QC and analysis roles. Above that band, a thinner premium tier of ₹8-15 LPA is reserved for medicinal chemistry, biotechnology and MBA (Pharm) marketing roles at Pfizer, Novartis, Biocon and Syngene. This means most NIPER Mohali students should anchor expectations around the ₹6 LPA median, while top performers in high-demand specialisations realistically target the ₹10-15 LPA premium offers.